Neovacs' IPO

Neovacs raised a round of funding on April 19, 2010. Investors include Public.

NeoVacs SA is a Paris based vaccine company working on anti-body therapies against human cytokines with a active immunization approach. Its platform is used to develop vaccine products that are induc…

Articles about Neovacs' IPO: